Authors:
Avinash Singh, Amit Patil
Download free PDF
Insect Repellent Market Size & Share 2026-2035
Report ID: GMI10119
|
Published Date: August 2026
|
Report Format: PDF/Excel/Dashboard/Platform
Download Free PDF
Explore Our Licensing Options:
Download Free PDF
Insect Repellent Market
Get a free sample of this report
Get a free sample of this report Insect Repellent Market
Is your requirement urgent? Please give us your business email
for a speedy delivery!
Insect Repellent Market Size
The global insect repellent market was valued at USD 5.9 billion in 2025 and is projected to reach USD 10.6 billion by 2035, expanding at a 6% CAGR over 2025-2035. According to the latest report published by Global Market Insights Inc., demand is widening beyond seasonal household use as mosquito- and tick-exposure concerns reach more consumer settings. The central commercial shift is from low-cost seasonal protection toward repeated purchases of topical, spatial, and household formats matched to different exposure profiles. Disease burden creates the demand floor, while premium delivery systems and wider digital access raise value per household.
Insect Repellent Market Key Takeaways
Market Leader: S.C. Johnson & Son, Inc. led with over 13% market share in 2025.
Leading Players: Top 5 players in this market include S.C. Johnson & Son, Inc., Reckitt Benckiser Group plc, Earth Corporation, Godrej Consumer Products Ltd, Sumitomo Chemical Co., Ltd., which collectively held a market share of 34% in 2025.
The market covers personal topical repellents, household coils, mats, vaporizers and diffusers, spatial systems, treated accessories, and related consumer formats. It excludes the wider professional pest-control market except where a consumer repellent product is part of the same offering. Estimates use a triangulated approach that reconciles category revenues, company and format coverage, regional demand patterns, and forecast growth drivers. The 2025 base year and 2025–2035 forecast window anchor all market calculations.
Vector-borne diseases remain the category’s clearest demand catalyst. WHO reports that vector-borne diseases cause more than 700,000 deaths annually, while malaria reached 282 million cases and 610,000 deaths in 2024. [1]World Health Organization - Vector-borne diseases and malaria data, who.int The 14.6 million dengue cases recorded in 2024 also turned repellent purchases into a more persistent health-protection decision in endemic markets. This relationship matters commercially because household demand no longer depends solely on a short mosquito season; it increasingly supports replenishment across tropical urban centers, travel periods, and outdoor-use occasions.
Premiumization will contribute as much to market expansion as unit growth through 2035. Household adoption of electric diffusers and vaporizers lifts spending relative to coils and mats, while roll-ons, sticks, wipes, and portable spatial devices extend the category into travel and outdoor occasions. Natural formulations add a separate value lever, although performance validation will decide whether those products can move from a niche preference into high-exposure use cases.
GMI Analyst View
The market will expand through 2035 because disease-led baseline demand and lifestyle-led discretionary demand reinforce one another rather than compete for the same purchase occasion. Vector exposure sustains demand for proven synthetic protection in endemic markets, while outdoor activity and ingredient transparency support premium topical and spatial formats in developed markets. The more consequential shift is the reduction in seasonality: products once purchased around summer peaks are moving into pharmacy, travel, and year-round household routines. By 2030, brands that pair documented efficacy with a format-specific convenience proposition will have more pricing power than brands competing only on familiar active ingredients.
Key Drivers
Disease incidence supplies the market’s non-discretionary demand layer. Dengue transmission affected more than 100 countries in 2024, and the record global case count has made personal and household protection more salient across endemic geographies. In high-burden markets, demand favors continuous household formats such as coils, mats, and electric vaporizers because overnight protection is the principal use case. The commercial implication is that brands with dense general-trade and pharmacy distribution can defend volume even when consumers trade down. In lower-incidence markets, the same health framing supports higher-value sprays, roll-ons, and treated accessories.
Urbanization and climate-related changes extend both vector range and exposure duration. Dense settlements increase breeding opportunities where water management is uneven, while warmer conditions lengthen mosquito activity in some temperate geographies. These shifts broaden the addressable market, but they also alter the product mix. Urban households typically value low-smoke, odor-controlled, plug-in, and topical solutions over commodity coils. As a result, geographic expansion can increase category revenue faster than it increases unit volumes.
Outdoor recreation supplies the category’s portable-format growth engine. The U.S. outdoor recreation economy generated USD 696.7 billion in 2024, equal to 2.4% of GDP. [2]U.S. Bureau of Economic Analysis - Outdoor recreation economy, bea.gov Participation reached 183.2 million people in 2025, supporting recurring demand for sprays, wipes, sticks, and treated gear among campers, hikers, and travelers. [3]Outdoor Industry Association - Outdoor participation data, outdoorindustry.org This channel favors products that can communicate duration, portability, and pest coverage clearly at the point of purchase. It also creates a route for outdoor specialists to compete without matching the household-distribution footprint of global incumbents.
Key Restraints
Safety concerns constrain the category where consumers associate conventional active ingredients with irritation or household exposure. DEET remains the most recognized active for broad protection, but families with children and wellness-oriented buyers often seek DEET-free options. CDC guidance continues to identify EPA-registered repellents, including DEET, as a core measure against mosquito and tick bites. [4]Centers for Disease Control and Prevention - Insect repellents and tick-borne disease guidance, cdc.gov The restraint is not an outright replacement of synthetics. It is a segmentation issue: brands must show why a formula’s active ingredient, concentration, and protection duration fit a defined use case.
Botanical positioning introduces a performance-management challenge. Peer-reviewed evidence indicates that plant-based repellents can have more variable efficacy and shorter protection duration than established synthetic alternatives, particularly against ticks. [5]Parasites & Vectors - Botanical insect repellent efficacy research, parasitesandvectors.biomedcentral.com This gap raises formulation costs because botanical brands must substantiate claims while preserving a clean-label proposition. The strongest commercial response is not a generic “natural” claim. It is a product architecture that specifies exposure context, reapplication expectations, and the limits of protection.
Regulatory requirements also slow new-product launches. Under the EU Biocidal Products Regulation, repellents and attractants fall under Product-type 19, requiring authorization before commercial placement. [6]European Chemicals Agency - Biocidal Products Regulation, Product-type 19, echa.europa.eu The U.S. Environmental Protection Agency similarly evaluates active ingredients and registered product claims, placing evidence and compliance at the center of formulation strategy. [7]U.S. Environmental Protection Agency - Repellent active ingredients and registered products, epa.gov Larger suppliers can spread dossier, testing, and registration costs across broader portfolios; smaller entrants face a heavier cost per launch. Regulation therefore acts as a quality threshold and a barrier to rapid SKU proliferation.
GMI Analyst View
Growth drivers outweigh restraints, but the category will not reward every formulation equally. Disease burden supports volume, whereas regulatory evidence determines which brands can claim premium efficacy and maintain consumer trust. The natural segment will grow faster than the market, yet synthetic actives will remain structurally important where protection duration and price per use govern purchase decisions. Through 2030, the winning proposition will combine credible claims, clear reapplication guidance, and a delivery format designed for a defined exposure setting.
Insect Repellent Market Segment Analysis
By Product Type
Vaporizers & Electric Diffusers accounted for 25.8% of 2025 market revenue, making them the largest product segment. Their scale reflects continuous indoor protection needs in urban Asian households, where overnight mosquito exposure is a recurrent concern. Sprays & Aerosols followed with 23.9% share because one format can serve personal, household, travel, and outdoor needs. OFF! Deep Woods Aerosol, Repel Sportsmen Max, and Mortein Power Booster illustrate how brands use broad distribution to capture different protection occasions. Coils held 14.8% share and mats held 8.1%, retaining relevance in price-sensitive areas even as urban households trade up.
The faster-growing formats are built around portability and controlled application. Oils & Roll-Ons and Sticks will each grow at a 7.6% CAGR, while Wipes will grow at 7.5%. These formats reduce overspray and fit travel, school, and outdoor routines where compact packaging matters. Thermacell LIV 2.0 represents a separate spatial-repellent model, supplying area protection rather than skin application. Wearables, Patches & Treated Accessories held 3.4% share and will grow at 4.7%, with OFF! Wearable Mosquito Repellent Clip and Insect Shield treated apparel providing branded examples of passive protection. The strategic divide is between formats purchased for repeated household use and formats selected for a defined activity or trip.
By Ingredient
Synthetic/Chemical-Based products held 68.1% of 2025 revenue. Their position rests on established efficacy, broad availability, and lower per-use cost in mainstream formats. DEET, picaridin, IR3535, and permethrin for clothing and gear remain central to this segment. CDC guidance identifies DEET as the best-studied option and recognizes permethrin as a treatment for clothing and equipment. This efficacy base is most valuable in high-exposure settings, where consumers are less willing to exchange duration for a natural positioning.
Natural/Botanical-Based products held 31.9% share and will grow at 7% CAGR. Citronella, oil of lemon eucalyptus, and PMD-based products appeal to ingredient-conscious consumers, while Undecanone adds a plant-derived active that has received EPA registration. The opportunity is not simply a shift away from synthetic chemistry. It is a move toward validated alternatives that can support protection claims in premium personal-care channels. ECHA’s PT19 framework matters because regulatory authorization can distinguish botanicals with documented claims from unverified “DEET-free” offers. By 2030, the category will separate into performance-led synthetics, validated botanical alternatives, and lower-evidence lifestyle products.
By Distribution Channel
Offline channels retained 64.6% of market revenue in 2025. Supermarkets, pharmacies, general trade, and outdoor specialty outlets remain central because consumers often purchase repellents alongside household staples, travel supplies, or health products. The channel is particularly resilient in emerging markets, where independent stores and pharmacies remain primary access points. Established portfolios from S.C. Johnson, Reckitt, and Godrej benefit from shelf presence, promotional programs, and regional distribution relationships.
Online channels held 35.4% share and will expand at a 6.4% CAGR, compared with 5.7% for offline channels. Digital distribution helps natural and specialty brands reach consumers without securing broad physical shelf space. Wondercide, Murphy’s Naturals, and W.S. Badger Company use online and specialty retail to reach buyers evaluating ingredients, family suitability, and product reviews. The second-order effect is faster category entry: lower slotting barriers give challenger brands a more direct path to discovery, but repeat purchases still depend on product performance rather than digital visibility alone.
GMI Analyst View
Format and ingredient choices are becoming interdependent. Portable roll-ons, wipes, and sticks make botanical propositions more practical for low-to-moderate exposure occasions, while diffusers and synthetic topicals remain stronger where duration and broad-area protection matter. Online retail will amplify this segmentation because it gives consumers more room to compare active ingredients and use cases than a conventional shelf label permits. By 2030, the category’s growth mix will favor products with a clear pairing of protection setting, active ingredient, and delivery format.
Insect Repellent Market Regional Analysis
North America
North America will be the fastest-growing region, advancing at a 6.5% CAGR through 2035. Outdoor participation and tick-borne disease awareness support demand for sprays, treated clothing, and portable formats. Lyme disease is the most commonly reported vector-borne disease in the United States, which keeps tick protection relevant beyond mosquito season. The EPA’s registered-active framework supports a premium market for products that can substantiate protection claims, including Undecanone-based and spatial-repellent formats. The key regional constraint is a more selective consumer who expects both safety and documented efficacy.
Europe
Europe accounted for 21.2% of 2025 revenue and will grow at a 6.3% CAGR. Germany, France, the UK, Italy, and Spain anchor demand through pharmacy, DIY, travel, and seasonal household channels. The Biocidal Products Regulation makes Product-type 19 authorization a central commercial requirement, increasing the value of regulatory capability. Union authorization EU-0032868-0000 demonstrates the role of a cross-market authorization route for biocidal product families. [8]EUR-Lex - Union authorization EU-0032868-0000, eur-lex.europa.eu Europe’s opportunity lies in premium, compliance-led innovation, but the authorization burden can delay smaller entrants and narrow the field of eligible claims.
Asia Pacific
Asia Pacific led the market with 39.7% share in 2025, equivalent to approximately USD 2.34 billion. Dense populations, endemic dengue exposure, and widespread household use make the region the category’s volume center. WHO disease data supports the connection between vector burden and recurring need for repellents and household protection formats. India, China, Indonesia, Japan, South Korea, and Australia illustrate different demand models: India and Indonesia support high-volume household formats, while Japan and South Korea reward technical differentiation and premium electric systems. Godrej’s Goodknight, Dabur’s Odomos, Earth Corporation, KINCHO, and PT. Enesis Group are positioned around those country-specific demand patterns.
Latin America and Middle East & Africa
Latin America benefits from dengue-related protection demand, with Brazil standing out as a large consumer market for household and personal formats. S.C. Johnson’s Guardian manufacturing investment in Pilar, Argentina, aligns capacity with regional distribution and public-health use cases. The Middle East & Africa combines high-volume, price-sensitive household demand with premium outdoor and hospitality consumption in Gulf markets. The regional constraint is a wide income and channel-access gap: coils and basic formats remain important in many areas, while premium spatial systems are concentrated in higher-income urban settings.
GMI Analyst View
Regional demand follows three distinct patterns: disease-led household protection in Asia Pacific and parts of Latin America, outdoor and tick-led premium demand in North America, and compliance-led innovation in Europe. These models require different product portfolios and channel investments. A single global brand can retain a common efficacy platform, but it cannot rely on one format or price architecture across all regions. Through 2030, the highest-value regional gains will come from adapting packaging, active-ingredient claims, and retail execution to local exposure conditions.
Insect Repellent Market Share & Competitive Landscape
S.C. Johnson & Son, Inc. led the market with a 13% share in 2025. Reckitt Benckiser Group plc held 7%, while Godrej Consumer Products Ltd. and Earth Corporation each held 5%, and Dainihon Jochugiku Co., Ltd. (KINCHO) held 4%. The top five companies collectively held 34% share, indicating a moderately concentrated market with substantial room for regional specialists and direct-to-consumer challengers.
S.C. Johnson competes through OFF!, Baygon, Autan, All Out, Fuyí, and its spatial-repellent program. Its advantage is breadth across regional household and personal-protection formats, reinforced by the public-health relevance of Guardian and Mosquito Shield. Reckitt’s Mortein franchise has strength across APAC, South Asia, and Africa, while its interest in wearable protection points to a technology-adjacent growth option. Godrej’s Goodknight portfolio is differentiated by its prominence in Indian household formats and Renofluthrin, an indigenously developed repellent molecule. Earth Corporation and KINCHO retain strong positions in Japanese electric diffuser, mat, and coil categories.
The competitive field also includes Spectrum Brands through Cutter and Repel; Dabur through Odomos; Sumitomo Chemical as an ingredient and specialty-chemicals participant; Jyothy Laboratories through Maxo; Haw Par through Tiger Balm; and PT. Enesis Group in Southeast Asia. Natural and outdoor-oriented brands such as Thermacell, Sawyer Products, Murphy’s Naturals, Wondercide, W.S. Badger Company, Quantum Health, Insect Shield, Newell Brands, Henkel, and Adventure Ready Brands address more specialized consumer needs. Their routes to market differ sharply: some rely on mass retail and pharmacy scale, while others use outdoor specialty, treated-textile partnerships, or digital channels.
Competitive advantage is shifting from brand awareness alone toward evidence-backed differentiation. Thermacell’s LIV 2.0 is an EPA-registered zone-protection system, demonstrating how a delivery system can create a defensible use case outside conventional topical repellents. In Europe, authorization capability can become a comparable moat because compliance determines whether a company can commercialize an active and make specific claims. The remaining 66% of market revenue is fragmented, but fragmentation does not mean low barriers; formulation science, registration, distribution access, and trusted efficacy claims each shape entry conditions.
GMI Analyst View
The market is unlikely to consolidate rapidly through 2030 because regional formats, local channels, and distinct exposure settings preserve room for specialists. Pricing power will increasingly depend on proprietary actives, validated duration claims, and delivery technologies rather than simple brand scale. Incumbents hold an advantage in regulatory infrastructure and distribution, while challengers can build share in online, botanical, wearable, and treated-accessory niches. The likely result is a layered market: global leaders will control broad household portfolios, while specialists capture premium occasions that require a narrower proposition.
Recent Industry Developments
Need a specific section of this report?
Purchase regional analysis, country-level analysis, company profiles, or any other segment-level insights separately
based on your research needs.
Table of Contents
Chapter 1 Methodology and Scope
Chapter 2 Executive Summary
Chapter 3 Industry Insights
Chapter 4 Competitive Landscape, 2025
Chapter 5 Market Estimates and Forecast, By Product Type, 2022 – 2035 (USD Billion) (Thousand Units)
Chapter 6 Market Estimates and Forecast, By Ingredient, 2022 – 2035 (USD Billion) (Thousand Units)
Chapter 7 Market Estimates and Forecast, By Insect Type, 2022 – 2035 (USD Billion) (Thousand Units)
Chapter 8 Market Estimates and Forecast, By Price, 2022 – 2035 (USD Billion) (Thousand Units)
Chapter 9 Market Estimates and Forecast, By End Use, 2022 – 2035 (USD Billion) (Thousand Units)
Chapter 10 Market Estimates and Forecast, By Distribution Channel, 2022 – 2035 (USD Billion) (Thousand Units)
Chapter 11 Market Estimates and Forecast, By Region, 2022 – 2035 (USD Billion) (Thousand Units)
Chapter 12 Company Profiles
Don't see your key competitors?
The companies listed in this report are a curated selection - not the full competitive universe.
Our market revenue calculations use a bottom-up methodology that accounts for all players across all regions - including manufacturers, distributors, and specialists not individually profiled. The profiles section spotlights strategically significant players; it does not define the scope of our market sizing.
Your competitive landscape may also include
Free customization - up to 20% of report value
Need specific data? Request customization and get the insights tailored to your exact requirements.
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Security & defense sector journals and trade press
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 30+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →